BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34884391)

  • 1. Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders.
    Gairing SJ; Galle PR; Schattenberg JM; Kostev K; Labenz C
    J Clin Med; 2021 Dec; 10(23):. PubMed ID: 34884391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal vein thrombosis is associated with an increased risk of bone fractures.
    Gairing SJ; Galle PR; Schattenberg JM; Kostev K; Labenz C
    PLoS One; 2022; 17(4):e0267535. PubMed ID: 35452487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany.
    Tilch MK; Galle PR; Schattenberg JM; Kostev K; Labenz C
    Support Care Cancer; 2022 Mar; 30(3):2387-2395. PubMed ID: 34761297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.
    Nery F; Chevret S; Condat B; de Raucourt E; Boudaoud L; Rautou PE; Plessier A; Roulot D; Chaffaut C; Bourcier V; Trinchet JC; Valla DC;
    Hepatology; 2015 Feb; 61(2):660-7. PubMed ID: 25284616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study.
    Stine JG; Wang J; Shah PM; Argo CK; Intagliata N; Uflacker A; Caldwell SH; Northup PG
    Liver Int; 2018 Jan; 38(1):94-101. PubMed ID: 28632958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
    Abdel-Razik A; Mousa N; Elhelaly R; Tawfik A
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis.
    Xing Y; Tian Z; Jiang Y; Guan G; Niu Q; Sun X; Han R; Jing X
    Ann Med; 2022 Dec; 54(1):302-309. PubMed ID: 35060835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis.
    Pan J; Wang L; Gao F; An Y; Yin Y; Guo X; Nery FG; Yoshida EM; Qi X
    Eur J Intern Med; 2022 Oct; 104():21-32. PubMed ID: 35688747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Portal Vein Thrombosis Prior to Liver Transplantation: A Retrospective Cohort Study.
    Karvellas CJ; Cardoso FS; Senzolo M; Wells M; Alghanem MG; Handou F; Kwapisz L; Kneteman NM; Marotta PJ; Al-Judaibi B
    Ann Hepatol; 2017; 16(2):236-436. PubMed ID: 28233745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors.
    Turon F; Driever EG; Baiges A; Cerda E; García-Criado Á; Gilabert R; Bru C; Berzigotti A; Nuñez I; Orts L; Reverter JC; Magaz M; Camprecios G; Olivas P; Betancourt-Sanchez F; Perez-Campuzano V; Blasi A; Seijo S; Reverter E; Bosch J; Borràs R; Hernandez-Gea V; Lisman T; Garcia-Pagan JC
    J Hepatol; 2021 Dec; 75(6):1367-1376. PubMed ID: 34333101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study.
    Noronha Ferreira C; Marinho RT; Cortez-Pinto H; Ferreira P; Dias MS; Vasconcelos M; Alexandrino P; Serejo F; Pedro AJ; Gonçalves A; Palma S; Leite I; Reis D; Damião F; Valente A; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Liver Int; 2019 Aug; 39(8):1459-1467. PubMed ID: 31021512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index.
    Gaballa D; Bezinover D; Kadry Z; Eyster E; Wang M; Northup PG; Stine JG
    Liver Transpl; 2019 Dec; 25(12):1747-1755. PubMed ID: 31436367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Factor VIII Activity Is Predictive of the Occurrence of Portal Vein Thrombosis in Cirrhosis.
    Jiang S; Ai Y; Fan X; Huang X; Wu L; Ni L; Li F; Chen S
    Thromb Haemost; 2023 Jul; 123(7):714-722. PubMed ID: 36913976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of portal vein thrombosis in cirrhosis: A systematic review with meta-analysis.
    Giri S; Singh A; Kolhe K; Kale A; Shukla A
    J Gastroenterol Hepatol; 2023 Oct; 38(10):1710-1717. PubMed ID: 37354011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial infections as a risk factor for non-neoplastic portal vein thrombosis development in cirrhotic patients.
    Dalbeni A; Cattazzo F; De Marco L; Bevilacqua M; Zoncapè M; Lombardi R; Stupia R; Mantovani A; Sacerdoti D
    Dig Liver Dis; 2024 Mar; 56(3):477-483. PubMed ID: 37778894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response.
    Mandorfer M; Turon F; Lens S; Baiges A; García-Criado Á; Darnell A; Belmonte E; Ferrusquía-Acosta J; Magaz M; Perez-Campuzano V; Olivas P; Bauer D; Casanovas G; Torres F; Mariño Z; Forns X; Hernández-Gea V; García-Pagán JC
    Liver Int; 2021 Dec; 41(12):2954-2964. PubMed ID: 34242479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers.
    Giannitrapani L; Granà W; Licata A; Schiavone C; Montalto G; Soresi M
    Med Princ Pract; 2018; 27(5):466-471. PubMed ID: 30107378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of insufficient recanalization and portal hypertensive complications after treatment of non-cirrhotic, non-malignant portal vein thrombosis - a population-based study.
    Lemma A; Åberg F; Mäkisalo H; Vikatmaa P; Mentula P; Leppäniemi A; Sallinen V
    Scand J Gastroenterol; 2020 Nov; 55(11):1324-1332. PubMed ID: 32976739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.